Opticept Technologies AbOMXSTO: OPTI

OPTI: Revenue up, losses down, and new funding to accelerate global commercialization

· Issued by Opticept Technologies AB

Q3 saw revenue growth, reduced losses, and major commercial agreements in food and plant tech. A SEK 80.4 million rights issue was announced to fund global expansion and commercialization, with strong open orders and a robust equity ratio.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.